Approach to imaging of the ovaries

Similar documents
A Practical Approach to Adnexal Masses

Category Term Definition Comments 1 Major Categories 1a

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

Assessment of adnexal masses. Ultrasound workup of adnexal masses. symptoms. symptoms. Age. Serum tumor markers 10/1/2018

IN THE NAME OF GOD POV: CYSTIC OVARIAN LESION

2/24/19. Ovarian pathology: IOTA ADNEXAL MASSES. Content. IOTA terms for description of an adnexal mass. IOTA terms for description of an adnexal mass

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Staging and Treatment Update for Gynecologic Malignancies

Diane DeFriend Derriford Hospital, Plymouth

بسم هللا الرحمن الرحيم. Prof soha Talaat

ISUOG Basic Training Typical Ultrasound Appearances of Common Pathologies in the Adnexae

Characterizing Adnexal Masses: Pearls and Pitfalls 20 th Annual Summer Practicum SCBT-MR Jackson Hole August 11, 2010

ACUTE PELVIC PAIN 강릉아산병원영상의학과 이은혜

Value of MRI in Characterizing Adnexal Masses

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Pathology of the female genital tract

Ovarian pathology: A practical approach to imaging diagnosis and management

H&E, IHC anti- Cytokeratin

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

- Posttreatment follow-up - Recurrent ovarian tumor resectability - Summary - References

Gynecologic Ultrasound. Sujata Ghate, MD Associate Professor of Radiology Duke University Medical Center

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Ovarian Lesion Benign vs Malignant?

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Endometrial Cancer. Incidence. Types 3/25/2019

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT.

Carcinoma of the Fallopian Tube

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer


Cervical Cancer: 2018 FIGO Staging

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Role of CT & MRI in the Evaluation of Pathologies in the Female Pelvis

CME ARTICLE. A Practical Approach to the Ultrasound Characterization of Adnexal Masses. Douglas L. Brown, MD

Pre-operative Evaluation and Implications

The many faces of Endometriosis

Does Ovarian Cysts affect your Fertility?

Normal Sonographic Anatomy

Interactive Staging Bee

Ultrasound Evaluation of Adnexal Pathologies Jagruti Kalola 1*, Hiral Hapani 2, Anjana Trivedi 3, Jay Thakkar 4

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Stage 3 ovarian cancer survival rate

Stage 3 ovarian cancer survival rate

OVARIAN CARCINOMA Immune Therapy. Antibodies to CA-125 (Ovarex) Vaccine therapy

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Case Fibrothecoma of the ovary

Endometrial Stromal Sarcoma

IMAGING GUIDELINES - COLORECTAL CANCER

Janjira Petsuksiri, M.D

CA125 in the diagnosis of ovarian cancer: the art in medicine

3 cell types in the normal ovary

Guidelines for Assigning Summary Stage 2000

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Imaging evaluation of ovarian masses.

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Adnexal Masses and Problem Solving Pelvic MRI

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.

JMSCR Vol 05 Issue 06 Page June 2017

Cancer: recent advances and implications for underwriting

3/25/ % arise from coelomic epithelium

Icd 10 ovarian stroma

A Tale of Two Ovaries: Cross-Sectional Imaging Spectrum of Ovarian Emergencies

MR Imaging of the Adnexal Masses: A Review

Ultrasound of Uterus and Ovary

STAGING AND FOLLOW-UP STRATEGIES

Triage of Ovarian Masses. Andreas Obermair Brisbane

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

CME. MRI of Ovarian Masses. Review. Hebert Alberto Vargas, MD, 1 * Tristan Barrett, MBBS, BSc, 2 and Evis Sala, MD, PhD 2

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

ENDOMETRIOSIS AS A COMMON CAUSE OF PELVIC PAIN

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

Categorization of Ovarian Dermoids Depending Upon Their Sonographic Appearances

Hitting the High Points Gynecologic Oncology Review

Neoplasia literally means "new growth.

Renal masses - the role of diagnostic imaging

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Ovarian Cancer What you need to know

The new FIGO classification in endometrial carcinoma

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

FDG-PET/CT in Gynaecologic Cancers

CAN TV U/S REDUCE THE

TUMOR,NEOPLASM. Pathology Department, Zhejiang University School of Medicine,

Terminology Estimate the risk of malignancy in adnexal masses - Overview

Top Tips for Gynaecological Ultrasound. Catherine Kirkpatrick Consultant Sonographer Dublin Oct 2018

Endometriosis - MRI findings with anatomic-pathologic correlation

Peritoneum: Def. : It is a thin serous membrane that lines the walls of the abdominal and pelvic cavities and clothes the viscera.

Case Report Delivery Induced Intraperitoneal Rupture of a Cystic Ovarian Teratoma and Associated Chronic Chemical Peritonitis

CASE STUDY. Presented by: Jessica Pizzo. CFCC Sonography student Class of 2018

Transcription:

First encounter Approach to imaging of the ovaries Mariam Moshiri MD Associate professor Body Imaging Most common first encounter is via ultrasound Many of clinicians order US imaging for various female pelvic complaints Therefore we need to start our diagnosfc approach and differenfal diagnosis based on ultrasound appearance of ovarian lesions First encounter differenfal diagnosis Our differenfal diagnosis will be based on the pafents menstrual status DifferenFal diagnosis of ovarian lesions somewhat different for pre vs. post menopausal women DifferenFal diagnosis for adnexal cysfc lesion: premenopausal Follicle (simple, hemorrhagic) Cyst (simple, hemorrhagic) Complex cyst (teratoma, enndometrioma, etc) Neoplasm (benign or malignant) Mullerian anomaly Abnormal pregnancy (ectopic) torsion DifferenFal diagnosis for adnexal cysfc lesion: postmenopausal Cyst (simple, complex) Neoplasm (benign or malignant) Mullerian anomaly Ultrasound Quarterly 2010; 26:121-131 This material should be referred to whenever one decides on further management/imaging recommendafons once an adnexal cysfc lesion is noted on ultrasound The chart is posted in the ultrasound reading room at UW 1

Simple cyst Hemorrhagic cyst Both ovarian and para-ovarian: Round or oval Anechoic Smooth, thin walls No septafons or solid component No internal flow ProducFve age: Less than or equal 5 cm: do nothing Between 5-7 cm: yearly follow up Postmenopausal: Between 1-7 cm: yearly follow up Larger than 7 cm: further imaging (MRI) or surgical evaluafon ReFcular pa^ern with internal echoes Fishnet appearance +/- solid appearing area with concave margins Daughter cyst No internal flow ProducFve age: Less than or equal 5 cm: do nothing More than cm: 6-12 week follow up to ensure resolufon Postmenopausal: Early: follow up unfl resolufon Late: consider surgical evaluafon Make sure there is no flow in the solid component on Doppler Endometrioma Homogeneous low level internal echoes No solid component May have Fny echogenic foci in the wall Focal or diffuse hyperechoic component Hyperechoic lines and dots Area of acousfc shadowing No internal flow Dermoid Any age: IniFal follow up 6-12 week, then yearly Any age: if not removed surgically, yearly follow up Tubular shaped cysfc structure Beads on string sign Waist sign Cogwheel sign Separate from ovary Hydrosalpinx Peritoneal inclusion cyst Follows the contours of the pelvis and adjacent structures Ovary at the edge of the mass or suspended from it May have septafons 2

No classic findings Findings not classic for hemorrhagic cyst, or endometrioma, or dermoid ProducFve age: 6-12 week follow up, if unchanged not likely hemorrhagic cyst Follow up with US or MRI If no diagnosis, consider surgical evaluafon CharacterisFcs worrisome for malignancy Thick irregular spetafons Nodule with blood flow Postmenopausal: Surgical evaluafon Consider surgical evaluafon Ovarian neoplasms Pa^ern of disease spread Serous Stromal Invasive Mucinous Surface epithelial Non-invasive Endometroid Germ cell Brenner : benign About 90% of ovarian cancers arise from the ovarian surface epithelium All peritoneal spaces communicate freely Malignant cells shed from the surface of the into the peritoneal cavity Peritoneal seeding is the most common mode of spread Peritoneal fluid is in constant circulafon by gravity and hydrostafcs Clear cell carcinoma UndifferenFated Pa^ern of disease spread Tumor cells spread by following the normal flow pa^ern of peritoneal circulafon Certain sites are favored due to relafve stasis They include: The flow pa^ern facilitates metastases within the peritoneal cavity Tumor cells may fall into cul-desac by gravity Tumor cells tend to flow along the paracolic gu^ers Rectouterine pouch Paracolic gu^ers Inferior extent of the small bowel mesentery in the right iliac fossa Morrison s pouch 3

Routes of disease spread They ogen coexist Tumor cells spread by following the normal flow pa^ern of peritoneal circulafon Direct spread along reflecfons LymphaFc spread Tumor emboli spread via the superior mesenteric artery and deposit on the anfmesenteric border of the bowel Intraperitoneal seeding Hematogenous embolic spread PreferenFal flow and seeding along the right paracolic gu^er, liver capsule and right hemidiaphragm Other common sites: Cul-de-sac Greater omentum Paracolic gu^ers CT images from leg to right and corresponding PET/CT: Subcapsular implant Mesenteric implant Omental caking Other common sites: Bowel surface seeding Liver capsule surface Subphrenic space through the round LymphaFc drainage pathway Main Pathway: LymphaFcs that follow the ovarian veins to para-aorfc and aortocaval lymph nodes through the broad through the round LymphaFc drainage pathway Main Pathway: LymphaFcs that follow the ovarian veins to para-aorfc and aortocaval lymph nodes through the broad Hematogenous spread Local extension to adjacent organs Least common at inifal presentafon More common at restaging Common sites: Liver, lung, adrenal glands, spleen, bone, brain Other sites: bladder Commonly involves uterus and fallopian tubes Other sites: rectum 4

Ovarian cancer staging Staging group TNM staging FIGO staging Ia T1aN0M0 IA Ib T1bN0M0 IB Ic T1cN0M0 IC IIa T2aN0M0 IIA IIb T2bN0M0 IIB IIc T2cN0M0 IIC Staging is performed by imaging as well as surgically DifferenFaFon between stage III and IV disease has direct impact on pafent management Ovarian cancer staging Presence of nodal metastases is an important prognosfc factor Stage III treated primarily by surgical debulking Stage IV treated primarily by chemotherapy and cytoreducfon IIIa T3aN0M0 IIIA IIIb T3bN0M0 IIIB IIIc T3cN0M0 Any TN1M0 IIIC IV Any T any N M1 IV Ovarian cancer staging Pleural effusion could be benign; Pleural effusion with pleural thickening or nodularity very likely malignant; may require thoracentesis to characterize PotenFal piialls in assigning FIGO stage IV disease Maybe difficult to differenfate between liver surface implants and true liver metastases, sagi^al/coronal reformates can be helpful Role of imaging in staging: CT Not very sensifve for characterizafon; Used for primary staging Very useful in determinafon of extent of and ancillary findings Role of imaging in staging: MRI T1WI, mulfplanar T2WI, and fat-sat T1WI with and without contrast are necessary Solid or cysfc adnexal mass Abnormal MRI Ascites, omental caking Very useful in characterizafon, determinafon of extent of, and ancillary findings Mural nodules, heterogeneous mass, necrosis Solid or cysfc adnexal mass Abnormal CT Ascites, omental caking Mural nodules, heterogeneous mass, necrosis Role of imaging in staging: PET/CT Brenner Uptake of 18-FDG in the normal ovaries limits use for detecfon of primary Uptake in benign lesions such as dermoid, corpus luteum and cystadenoma limits detecfon of primary While evaluafng primary, differenfafon of benign from malignant lesion on 18-FDG PET alone is not possible 18-FDG PET needs to be correlated with a diagnosfc CT or MRI examinafon Epithelial 30% associated with another epithelial of the ovary Solid mass on US T1 and T2 low SI Uptake in the ovaries of postmenopausal pafent is considered suspicious PET/CT imaging has a more important role in surveillance and restaging of ovarian carcinoma 5

Fibrothecoma Sex cord/stromal Can secrete estrogen Maybe hypoechoic on US with some shadowing or just a non specific solid mass T1 low SI, T2 low SI Criteria indicafve of PCOS Increased ovarian size more than 10cc, can be unilateral 12 or more follicles measuring 2-9mm, can be unilateral Follicles of similar size with peripheral locafon String of pearl sign Hyerechoic centeral stroma FerFl Steril 2004; 81:19-25 6